Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

8.400 -0.020 (-0.24%)

Streaming Delayed Price Updated: 1:35 PM EDT, Jun 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Is ADMA Biologics Gaining or Losing Market Support? ↗

August 01, 2025

Via Benzinga

Is ADMA Biologics Gaining or Losing Market Support? ↗

July 02, 2025

Via Benzinga

How Is The Market Feeling About ADMA Biologics? ↗

June 04, 2025

Via Benzinga

Adma Biologics (ADMA) Q2 Revenue Up 14% ↗

August 06, 2025

Via The Motley Fool

Topics Economy

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

August 06, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

July 30, 2025

Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria ↗

June 13, 2025

ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.

Via Chartmill

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

ADMA Biologics Earnings Preview ↗

May 06, 2025

Via Benzinga

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential ↗

June 09, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup ↗

June 07, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock ↗

June 03, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing. ↗

May 09, 2025

Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings ↗

May 08, 2025

Via Benzinga

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits ↗

May 08, 2025

The company makes immunoglobulin products using donated plasma.

Via Investor's Business Daily

Topics Earnings

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 07, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

3 Mid-Cap Medical Stocks Outperforming the Market

May 06, 2025

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

Via MarketBeat

Topics Economy

Should you consider ADMA BIOLOGICS INC (NASDAQ:ADMA) for growth investing? ↗

May 05, 2025

A fundamental analysis of (NASDAQ:ADMA): Exploring growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).

Via Chartmill

Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick? ↗

May 01, 2025

A fundamental and technical analysis of (NASDAQ:ADMA): Exploring ADMA BIOLOGICS INC (NASDAQ:ADMA)'s high growth characteristics.

Via Chartmill

ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate ↗

May 01, 2025

ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate

Via Chartmill

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

April 30, 2025

Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

What's Going On With ADMA Stock Monday? ↗

April 28, 2025

ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.

Via Benzinga

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday ↗

April 28, 2025

Via Benzinga

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

From FN Media Group LLC

Via GlobeNewswire

IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval ↗

April 28, 2025

The company says a new process will improve its output by 20%, benefitting revenue and earnings later this year.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.